Home » Topics » BioWorld Science, Respiratory

BioWorld Science, Respiratory
RSS

Cystic Fibrosis Foundation award supports development of Peptilogics' PLG-0301 and PLG-0206

Jan. 7, 2022

Study shows nanoparticles could help reduce acute lung inflammation in COVID-19

Jan. 5, 2022

Respiratory

Jan. 1, 2022

Claritas to develop R-107 for persistent pulmonary hypertension of the newborn

Dec. 23, 2021

Chiesi identifies new discoidin domain-containing receptor inhibitors

Dec. 22, 2021

Sanofi patents IL-17A/IL-17RA interaction inhibitors

Dec. 17, 2021

Shanghai Litedd presents new nuclear receptor RORgammaT antagonists

Dec. 7, 2021

C4X Discovery Holdings patents NFE2L2 activators

Nov. 16, 2021

Heptares Therapeutics patents histamine H4 receptor antagonists

Nov. 15, 2021

Researchers develop CFTR-mutated cystic fibrosis murine model to allow gene-editing strategies

Nov. 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.